These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35634240)

  • 1. Identification of lung cancer drivers by comparison of the observed and the expected numbers of missense and nonsense mutations in individual human genes.
    Gorlova OY; Kimmel M; Tsavachidis S; Amos CI; Gorlov IP
    Oncotarget; 2022; 13():756-767. PubMed ID: 35634240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene characteristics predicting missense, nonsense and frameshift mutations in tumor samples.
    Gorlov IP; Pikielny CW; Frost HR; Her SC; Cole MD; Strohbehn SD; Wallace-Bradley D; Kimmel M; Gorlova OY; Amos CI
    BMC Bioinformatics; 2018 Nov; 19(1):430. PubMed ID: 30453881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-exome sequencing to identify novel somatic mutations in squamous cell lung cancers.
    Zheng CX; Gu ZH; Han B; Zhang RX; Pan CM; Xiang Y; Rong XJ; Chen X; Li QY; Wan HY
    Int J Oncol; 2013 Sep; 43(3):755-64. PubMed ID: 23799614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsense and missense mutation of mitochondrial ND6 gene promotes cell migration and invasion in human lung adenocarcinoma.
    Yuan Y; Wang W; Li H; Yu Y; Tao J; Huang S; Zeng Z
    BMC Cancer; 2015 May; 15():346. PubMed ID: 25934296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Untouchable genes in the human genome: Identifying ideal targets for cancer treatment.
    Gorlov IP; Gorlova OY; Amos CI
    Cancer Genet; 2019 Feb; 231-232():67-79. PubMed ID: 30803560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of nonsense mutations causing human genetic disease.
    Mort M; Ivanov D; Cooper DN; Chuzhanova NA
    Hum Mutat; 2008 Aug; 29(8):1037-47. PubMed ID: 18454449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic determinants of lung cancer: Understanding the oncogenic potential of somatic missense mutations.
    Dhakar R; Dakal TC; Sharma A
    Genomics; 2022 Jul; 114(4):110401. PubMed ID: 35709927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Likelihood models of somatic mutation and codon substitution in cancer genes.
    Yang Z; Ro S; Rannala B
    Genetics; 2003 Oct; 165(2):695-705. PubMed ID: 14573481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma.
    Sun H; Liu SY; Zhou JY; Xu JT; Zhang HK; Yan HH; Huan JJ; Dai PP; Xu CR; Su J; Guan YF; Yi X; Yu RS; Zhong WZ; Wu YL
    EBioMedicine; 2020 Oct; 60():102990. PubMed ID: 32927274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Features of missense/nonsense mutations in exonic splicing enhancer sequences from cancer-related human genes.
    Jin P; Cai R; Zhou X; Li-Ling J; Ma F
    Mutat Res; 2012 Dec; 740(1-2):6-12. PubMed ID: 23123687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsynonymous, synonymous and nonsense mutations in human cancer-related genes undergo stronger purifying selections than expectation.
    Chu D; Wei L
    BMC Cancer; 2019 Apr; 19(1):359. PubMed ID: 30991970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing.
    Zhao J; Sun Y; Huang Y; Song F; Huang Z; Bao Y; Zuo J; Saffen D; Shao Z; Liu W; Wang Y
    Sci Rep; 2017 Jan; 7():40488. PubMed ID: 28091594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic imbalance of somatic mutations in cancer genomes and transcriptomes.
    Rhee JK; Lee S; Park WY; Kim YH; Kim TM
    Sci Rep; 2017 May; 7(1):1653. PubMed ID: 28490743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strength of selection in lung tumors correlates with clinical features better than tumor mutation burden.
    Gorlov IP; Gorlova OY; Tsavachidis S; Amos CI
    Sci Rep; 2024 Jun; 14(1):12732. PubMed ID: 38831004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Origins of nonsense mutations in human tumor suppressor genes.
    Zhang M; Yang D; Gold B
    Mutat Res; 2021; 823():111761. PubMed ID: 34461460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer.
    Gemma A; Seike M; Seike Y; Uematsu K; Hibino S; Kurimoto F; Yoshimura A; Shibuya M; Harris CC; Kudoh S
    Genes Chromosomes Cancer; 2000 Nov; 29(3):213-8. PubMed ID: 10992296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel and recurrent germline and somatic mutations in a cohort of 67 patients from 48 families with Brooke-Spiegler syndrome including the phenotypic variant of multiple familial trichoepitheliomas and correlation with the histopathologic findings in 379 biopsy specimens.
    Grossmann P; Vanecek T; Steiner P; Kacerovska D; Spagnolo DV; Cribier B; Rose C; Vazmitel M; Carlson JA; Emberger M; Martinek P; Pearce RL; Pearn J; Michal M; Kazakov DV
    Am J Dermatopathol; 2013 Feb; 35(1):34-44. PubMed ID: 23249834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutated ephrin receptor genes in non-small cell lung carcinoma and their occurrence with driver mutations-targeted resequencing study on formalin-fixed, paraffin-embedded tumor material of 81 patients.
    Mäki-Nevala S; Kaur Sarhadi V; Tuononen K; Lagström S; Ellonen P; Rönty M; Wirtanen A; Knuuttila A; Knuutila S
    Genes Chromosomes Cancer; 2013 Dec; 52(12):1141-9. PubMed ID: 24123310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
    Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E
    Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.